A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects

Clinical trial NCT05646758 · UNKNOWN

Trial details

NCT number: NCT05646758
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2023-03-17
Primary completion: 2024-10-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.